Efficacy and Safety of RZL-012 on Submental Fat Reduction

NCT04867434 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

INDUSTRY

Sponsor class

Conditions

Submental Fat

Interventions

DRUG: RZL-012
DRUG: Placebo

Sponsor

Raziel Therapeutics Ltd.